Lepu Biopharma
Founded in Jan 2018 by Dr. Pu Zhongjie, Lepu Biotech focuses on tumor immunotherapy, R&D, production, and sales of targeted therapy drugs.
Launch date
Employees
Market cap
AUD979m
Enterprise valuation
AUD1.0b (Public information from Sep 2024)
Share price
HKD2.96 2157.HK
Songjiang District China (HQ)
Authorizing premium user...